EMR Technology Solutions 10-Q 13 Aug 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Aug. 13, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	EMR Technology Solutions, Inc.
Entity Central Index Key	0001687999
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Incorporation State Country Code	NV
Entity Interactive Data Current	Yes
Entity Ex Transition Period	false
Entity File Number	000-55715
Entity Common Stock, Shares Outstanding		10,151,854

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 2,610	$ 2,610
Accounts receivable, net	18,710	17,118
Prepaid Expenses	3,240	3,240
Total Current Assets	24,560	31,343
Other Assets:
Security Deposit	1,450	1,450
Software, net		36,250
Customer lists, net	38,266	57,936
Total other assets	39,716	95,636
TOTAL ASSETS	64,276	126,979
Current Liabilities:
Accounts payable	422,103	383,035
Accrued expenses	712,485	641,665
Deferred revenue	49,478	45,223
Factor advance, net	55,700	79,701
Promissory notes - current portion	533,037	533,037
Promissory notes - related party - current portion	645,550	645,550
Total Current Liabilities	2,418,353	2,328,211
TOTAL LIABILITIES	2,418,353	2,328,211
Commitments and Contingencies (See Note 4)
Stockholders' Deficit:
Common Stock, 70,000,000 shares authorized, $.001 par value, 10,151,854 and 10,151,854 shares issued and outstanding in 2020 and 2019, respectively	10,152	10,152
Additional paid in capital	4,081,372	4,081,372
Accumulated deficit	(6,445,601)	(6,292,756)
Total stockholders' deficit	(2,354,077)	(2,201,232)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 64,276	$ 126,979

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	10,151,854	10,151,854
Common stock, shares outstanding	10,151,854	10,151,854

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues:
Service revenues	$ 33,795	$ 78,239
Contract revenues	74,444	110,445
Total revenues	108,239	188,684
Cost and expenses:
Costs of revenues	12,762	23,275
Selling, general, and administrative expense	138,502	207,889
Amortization expense	55,920	145,950
Total operating expenses	207,184	377,114
Loss from operations	(98,945)	(188,430)
Other Income (Expense)
Interest expense (net)	(53,900)	(38,507)
Total other income (expense)	(53,900)	(38,507)
Loss before income taxes	(152,845)	(226,937)
Provision for income taxes
Net Loss	$ (152,845)	$ (226,937)
Basic and diluted net loss per common share	$ (0.01)	$ (0.02)
Weighted Average Number of Common Shares – Basic and diluted	10,151,854	10,064,558

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Equity (Deficit) (Unaudited) - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 10,065	$ 4,034,572	$ (5,227,652)	$ (1,183,015)
Balance, shares at Dec. 31, 2018	10,064,754
Cancellation of Common Stock		(410)		(410)
Cancellation of Common Stock, shares	(400)
Net Loss			(226,937)	(226,937)
Balance at Mar. 31, 2019	$ 10,065	4,034,162	(5,454,589)	(1,410,362)
Balance, shares at Mar. 31, 2019	10,064,354
Balance at Dec. 31, 2019	$ 10,152	4,081,372	(6,292,756)	(2,201,232)
Balance, shares at Dec. 31, 2019	10,151,854
Net Loss			(152,845)	(152,845)
Balance at Mar. 31, 2020	$ 10,152	$ 4,081,372	$ (6,445,601)	$ (2,354,077)
Balance, shares at Mar. 31, 2020	10,151,854

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flows From Operating Activities:
Net Loss	$ (152,845)	$ (226,937)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization	55,920	145,950
Provision for (recovery of) bad debt	942	(1,565)
Amortization of debt discount	7,371	17,089
Changes in operating assets and liabilities:
Accounts receivable	(2,534)	27,933
Accounts payable and accrued expenses	109,888	56,341
Deferred revenue	4,255	(43,815)
Net Cash Provided by (Used in) Operating Activities	22,997	(25,004)
Cash Flows From Financing Activities:
Proceeds from factoring advance		95,000
Repayment of factoring advance	(31,372)	(71,706)
Payment for cancellation of shares		(410)
Net Cash Provided by (Used in) Financing Activities	(31,372)	22,884
Net Change in Cash and cash equivalents	(8,375)	(2,120)
Cash and cash equivalents at Beginning of the Period	2,610	10,985
Cash and cash equivalents at End of the Period	2,610	2,610
Supplemental cash flow information:
Cash paid for interest	6,250	16,500
Cash paid for taxes
Non Cash Investing & Financing Activities:
Accrued interest converted into promissory note		$ 12,500

Summary of Significant Accounti

Summary of Significant Accounting Policies and Organization	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (A) Basis of Presentation The accompanying condensed consolidated unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations. It is management’s opinion that all material adjustments (consisting of normal recurring adjustments) have been made, which are necessary for a fair financial statements’ presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. The Company is a Nevada corporation formed on November 3, 2015. It was formed as a holding company whose principal activities consists of acquiring healthcare technology companies. Its fiscal year end is December 31. To date, the Company has financed and acquired four electronic medical records companies. (B) Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include the allocation of purchase price to fair value of assets acquired, valuation of deferred taxes, allowance for bad debt, useful lives of intangible assets, and stock-based compensation. (C) Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At March 31, 2020 and December 31, 2019, the Company had no cash equivalents. (D) Accounts Receivable Accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. Specific reserves are estimated by management based on certain assumptions and variables, including the customer’s financial condition, age of the customer’s receivables, and changes in payment histories. Accounts receivable are written off when management determines the likelihood of collection is remote. Interest is not charged on accounts receivable that are past due. The Company recorded an allowance for doubtful accounts of $942 and $0 as of March 31, 2020 and December 31, 2019, respectively. (E) Principles of Consolidation The 2020 and 2019 consolidated financial statements include the operations of EMR Technology Solutions, Inc. (“EMR”), its wholly owned subsidiaries First Medical Solutions, Inc. (“FMS”), EMRgence, LLC (“EMRG”), Empower Technologies, Inc. (“ETI”), and Digital Medical Solutions, Inc. (“DMSI”). All significant intercompany accounts and transactions have been eliminated in consolidation. (F) Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The tax returns for the years ended December 31, 2019, 2018, 2017, and 2016 are subject to examination by the Internal Revenue Service. (G) Furniture and Computer Equipment Office Furniture and Computer Equipment are capitalized at cost, net of accumulated depreciation. Depreciation is calculated by using the straight-line method over the estimated useful lives of the assets, which is five to seven years for all categories. Repairs and maintenance are charged to expense as incurred. Expenditures for betterments and renewals are capitalized. The cost of computer equipment and the related accumulated depreciation are removed from the accounts upon retirement or disposal with any resulting gain or loss being recorded in operations. Asset Category Period Furniture and fixtures 7 Years Computer equipment 3 Years (H) Amortization and Impairment of Long-Lived Assets Amortization and Impairment of long-lived assets are non-cash expenses relating primarily to intangible assets. The Company accounts for long-lived assets in accordance with the provisions of FASB ASC 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets”. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Software costs are amortized over three (3) years. Non-compete costs are amortized over three (3) years and Customer Lists are amortized over three (3) years. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. As of March 31, 2020, and December 31, 2019, we have recorded impairments of $0 and $0, respectively. For the three months ended March 31, 2020 and the three months ended March 31, 2019, amortization expense was $55,920 and $145,950, respectively. (I) Fair Value Measurements and Fair Value of Financial Instruments The Company adopted FASB ASC Topic 820, Fair Value Measurements. ASC Topic 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The Company did not identify any assets or liabilities that are required to be presented on the balance sheets at fair value in accordance with ASC Topic 820 (F). (J) Advertising Advertising costs are expensed as incurred. For the three months ended March 31, 2020 and March 31, 2019, the Company incurred $0 and $0, respectively. (K) Business Segments The Company operates in one segment and therefore segment information is not presented. (L) Revenue Recognition The Company accounts for revenue in accordance with Topic 606, which the Company adopted on January 1, 2018, using the modified retrospective method. The adoption of Topic 606 did not have a material impact on the timing or amounts of revenue recognized in our unaudited condensed consolidated financial statements and therefore did not have a material impact on our financial position, results of operations, equity or cash flows as of the adoption date or for the three months ended March 31, 2020. The Company did not recognize any cumulative-effect adjustment to retained earnings upon adoption as the impact was immaterial. Also, the comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. Revenues are recognized when the Company satisfies a performance obligation by transferring control of the promised goods or services to our customers at a point in time, in an amount specified in the contract with our customer and that reflects the consideration The Company expect to be entitled to in exchange for those goods or services. The Company also assesses our customer’s ability and intention to pay, which is based on a variety of factors including our customer’s historical payment experience and financial condition. The Company derives revenue from the sale of software licenses when the products are installed and all required post implementation services are completed. The Company recognizes revenue from consulting services as the services are performed. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer under Topic 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The majority of our contracts with customers contain a single performance obligation to provide agreed-upon products or services. For contracts with multiple performance obligations, we allocate revenue to each performance obligation based on its relative standalone selling price. In accordance with Topic 606, we do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer. The timing of our performance often differs from the timing of invoicing, which results in the recording of deferred revenue. Deferred revenue will be recognized when performance obligation is satisfied. (M) Stock-Based Compensation The Company accounts for stock-based instruments issued to employees for services in accordance with ASC Topic 718. ASC Topic 718 requires the Company to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an employee award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. This standard was effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity’s adoption of Topic 606. The adoption of this ASU has no material impact on our results of operations, cash flows or financial condition. (N) Cost of Revenue Cost of revenue consists primarily of sub-contractor costs related to personnel who provide services to our customers, co-location costs, and other direct costs related to our services. Costs associated with the implementation of new customers are expensed as incurred. (O) Basic and Diluted Net Loss Per Common Share In accordance with ASC 260-10, “Earnings Per Share”, basic net loss per common share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted loss per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. As of March 31, 2020 and March 31, 2019, the Company has 1,157,133 and 955,038 shares of common stock issuable upon the conversion of notes payable and 90,000 and 90,000 shares of common stock issuable upon the exercise of options, respectively, that were not included in the computation of dilutive loss per share because their inclusion is anti-dilutive. (P) Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02 “Leases,” which will amend current lease accounting to require lessees to recognize (i) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis, and (ii) a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ASU 2016-02 does not significantly change lease accounting requirements applicable to lessors; however, certain changes were made to align, where necessary, lessor accounting with the lessee accounting model. This standard was effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The adoption of this ASU has no material impact on our results of operations, cash flows, or financial condition because the Company’s leases are less than 12 months. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2020
Going Concern [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company sustained a net loss for the three months ended March 31, 2020. The Company also has a working capital deficit and an accumulated deficit at March 31, 2020. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital to sustain its current level of operations. Management plans to continue raising additional capital through private placements and is exploring additional avenues for future fund-raising through both public and private sources. The unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Promissory Notes and Factor Adv

Promissory Notes and Factor Advances	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
PROMISSORY NOTES AND FACTOR ADVANCES	NOTE 3 – PROMISSORY NOTES AND FACTOR ADVANCES The $700,000 FMS Note to a related party has an interest rate of ten percent (10%) per annum for a period of two (2) years and fully amortizes during the third (3rd) year. The related party is the Company’s Chief Technology Officer. The note can be converted at any time, at the option of the holder, into shares of the Company’s stock at a conversion price of $1.00 per share. On October 31, 2016, the holder of the FMS Note converted $200,000 of the note for 200,000 shares of common stock. The Company has recorded loss on conversion of debt of $72,000. On November 15, 2017, the Board of Directors approved an amendment to the FMS Note changing the conversion provision from $3.00 per share to $1.00 per share. On December 31, 2017, the holder of the FMS Note converted $25,000 of interest due for 25,000 shares of common stock. On June 30, 2018, September 30, 2018, and December 31, 2018, the holder of the FMS Note converted $33,038 of interest due for each period to additional principal on the FMS Note accruing at six percent (6.0%) annual interest. On June 30, 2019, the FMS Note was amended to change the beginning repayment period from June 30, 2019 to September 30, 2019 for 3 quarterly installments thereafter. The payments due on September 30, 2019, December 31, 2019, and March 31, 2020 were not paid and the noteholder has not notified the Company of any event of default. The Company issued a three (3) year convertible promissory note (the “EMRG Note”) for two hundred thousand dollars ($200,000). The EMRG Note has an interest rate of eight percent (8%) per annum for a period of one (1) years and fully amortizes during the next two (2) years. The note is secured with a pledge of forty percent (40%) of the membership interests acquired. The note can be converted at any time, at the option of the holder, into shares of the Company’s stock at a conversion price of $3 per share. On December 29, 2017, the EMRG Note was amended to change the beginning repayment period from December 31, 2017 to March 31, 2018 for $50,000 and 7 equal quarterly installments of $25,000 each thereafter and the interest rate was increased from 6% to 8% annually. On March 31, 2018, the EMRG Note was amended to change the beginning repayment period from March 31, 2018 to October 1, 2018 for $100,000 and 4 equal quarterly installments of $25,000 each thereafter. On September 30, 2018, the EMRG Note was amended to change the beginning repayment period from March 31, 2018 to January 1, 2019 for $125,000 and 3 equal quarterly installments of $25,000 each thereafter. Effective January 1, 2019, the EMRG Note was amended to change the beginning repayment period from January 1, 2019 to June 30, 2019 for $125,000 and 2 equal quarterly installments of $37,500 each thereafter. On June 30, 2019, the EMRG Note was amended to change the principal payment of $200,000 and accrued interest to October 31, 2019. The payments due on October 31, 2019 were not paid and the noteholder has not notified the Company of any event of default. The Company issued a three (3) year unsecured convertible promissory note (the “ETI Note”) for one hundred fifty thousand dollars ($150,000). The ETI Note has an interest rate of six percent (6%) per annum for a period of two (2) years and fully amortizes during the third (3rd) year. The note can be converted at any time, at the option of the holder, into shares of the Company’s stock at a conversion price of $3 per share. Effective March 31, 2019, the ETI Note was amended to change the beginning repayment period from March 31, 2019 to September 30, 2019 for $37,500 and 3 equal quarterly installments of $37,500 each thereafter. On March 31, 2019, the Board of Directors approved an amendment to the ETI Note changing the conversion provision from $3.00 per share to $1.00 per share. On June 30, 2019, the ETI Note was amended to change the beginning repayment period to September 30, 2019 for $75,000 and 2 quarterly installments of $37,500 thereafter The payments due on September 30, 2019, December 31, 2019, and March 31, 2020 were not paid and the noteholder has not notified the Company of any event of default. The Company issued a three (3) year unsecured convertible promissory note (the “DMSI Note”) for two hundred fifty thousand dollars ($250,000). The DMSI Note has an interest rate of six percent (6%) per annum for a period of one (1) year and fully amortizes during the next two (2) years. The note can be converted at any time, at the option of the holder, into shares of the Company’s stock at a conversion price of $1.00 per share. On December 20, 2017, the Agreement was amended to remove the purchase price adjustment for EBITDA. On December 20, 2017, the Note was amended to change the interest only period from one year to two years, changing the beginning of principal payments from December 31, 2017 to December 31, 2018 and to increase the annual interest rate from 6% to 8% commencing January 1, 2018. On December 22, 2017, the Board of Directors approved an amendment to the Note changing the conversion provision from $3.00 per share to $1.00 per share. On December 29, 2017, the Board of Directors approved the request by the holder of the DMSI Note to convert $50,000 principal of the DMSI Note into 50,000 shares of the Company’s common stock. On December 31, 2018, the DMSI Note was amended to change the beginning repayment period from December 31, 2018 to June 30, 2019 for $50,000 and 3 quarterly installments of $50,000 thereafter. On April 30, 2019, $95,550 of accounts payable was added the DMSI Note. On June 30, 2019, the DMSI Note was amended to change the beginning repayment period from June 30, 2019 to September 30, 2019 for 3 quarterly installments. The payments due on September 30, 2019, December 31, 2019, and March 31, 2020 were not paid and the noteholder has notified the Company of an event of default. On March 15, 2019, the Company entered into a Revenue Based Factoring Agreement with a third party. Under the agreement, the Company has sold $124,450 (the “Purchase Price”) in future accounts and contract rights for $95,000. The advance was received by the Company on March 15, 2019. A portion of the proceeds was used to satisfy the balance due on the September 26, 2018 Factoring Agreement described above. The difference between the amount sold and the purchase price of $29,450 has been recorded as a debt discount. In exchange for the purchased amount, the Company authorized the third party to ACH debit $506 daily from the Company’s bank account until the purchased amount is fully received. On October 31, 2019, the Company entered into a Revenue Based Factoring Agreement with a third party. Under the agreement, the Company has sold $124,450 (the “Purchase Price”) in future accounts and contract rights for $95,000. The advance was received by the Company on November 1, 2019. A portion of the proceeds was used to satisfy the balance due on the March 15, 2019 Factoring Agreement described above. The difference between the amount sold and the purchase price of $29,450 has been recorded as a debt discount. In exchange for the purchased amount, the Company authorized the third party to ACH debit $506 daily from the Company’s bank account until the purchased amount is fully received. As of December 31, 2019, the balance due was $79,701, net of debt discount of $24,509. The Company amortized $5,122 of debt discount during the year ended December 31, 2019. As of March 31, 2020, the balance due was $72,838, net of debt discount of $17,138.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 4 – COMMITMENTS AND CONTINGENCIES On January 15, 2017, the Company entered into a two-year lease for office space, effective January 15, 2017 for a monthly rent of $1,143 per month. The lease expired January 31, 2019. On January 15, 2020, the Company entered into a one-year lease. The monthly rent is $1,228. Rent expense for the three months ended March 31, 2020 and March 31, 2019 was $3,718 and $3,628, respectively. We face risks related to novel coronavirus (Covid-19) which could significantly disrupt our operations, sales, and financial results. Our business will be adversely impacted by the effects of the novel coronavirus (Covid-19). In addition to global macroeconomic effects, the novel coronavirus (Covid-19) outbreak and any other related adverse public health developments will cause disruption to our operations and sales activities. Our suppliers, third-party distributors, sub-contractors and customers have been and will be disrupted by worker absenteeism, quarantines, and restrictions on our employees’ ability to work, office closures, or other travel or health-related restrictions. In addition, the novel coronavirus (Covid-19) or other disease outbreak will in the short-run and may over the longer term adversely affect the economies and financial markets, resulting in an economic downturn that will affect demand for our products and impact our operating results. There can be no assurance that any decrease in revenues resulting from the novel coronavirus (Covid-19) will be offset by increased revenues in subsequent periods. Although the magnitude of the impact of the novel coronavirus (Covid-19) outbreak on our business and operations remains uncertain, the continued spread of the novel coronavirus (Covid-19) or the occurrence of other epidemics and the imposition of related public health measures, travel and business restrictions will adversely impact our business, financial condition, operating results, and cash flows. In addition, we have experienced and will experience disruptions to our business operations resulting from quarantines, self-isolations, or other movement and restrictions on the ability of our employees to perform their jobs that may impact our ability to develop and design our products in a timely manner or meet required milestones or customer commitments.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
STOCKHOLDERS' EQUITY	NOTE 5 – STOCKHOLDERS’ EQUITY (A) - Stock issued for cash Effective February 15, 2019, by mutual agreement, the Company and two shareholders representing 400 shares of common stock of the Company issued in October 2017, cancelled said shares and refunded $410 to the shareholders. (B ) - Equity Incentive Plan On January 30, 2016, the Board of Directors, with the approval of a majority of the shareholders of the Company, adopted the 2016 Equity Incentive Plan (the “Plan”) which will be administered by a committee appointed by the Board. The Company, under its 2016 Plan, issues options to various officers, directors and consultants. The options vest in equal annual installments over a five-year period. All of the options are exercisable at a purchase price based on the last price of the Company’s common stock on the date of grant and have a term of 10 years. The following sets forth the options granted and outstanding as of March 31, 2020: Number of Weighted Granted Intrinsic Options outstanding at December 31, 2019 90,000 $ 0.001 90,000 $ 0 Granted -- -- -- -- Exercised -- -- -- -- Forfeited/Expired -- -- -- -- Options outstanding at March 31, 2020 90,000 $ 0.001 90,000 $ 0

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 6 – SUBSEQUENT EVENTS On April 27, 2020, the Company entered into a Revenue Based Factoring Agreement with a third party. Under the agreement, the Company has sold $100,632 (the “Purchase Price”) in future accounts and contract rights for $76,818. The advance was received by the Company on April 28, 2020. A portion of the proceeds was used to satisfy the balance due on the October 31, 2019 Factoring Agreement described above. The difference between the amount sold and the purchase price of $23,814 has been recorded as a debt discount. In exchange for the purchased amount, the Company authorized the third party to ACH debit $421 daily from the Company’s bank account until the purchased amount is fully received. On May 11, 2020, the Company received $46,400 from the Paycheck Protection Program (the “Loan”) established under the CARES Act (The Coronavirus Aid, Relief, and Economic Security Act) of 2020. The proceeds of this loan may be fully forgiven in the event that at least 60% is used for payroll and the balance for utilities within the first 24 weeks of receipt of the proceeds. The Company intends to use the entire proceeds on payroll and anticipates that the Loan will be forgiven. On June 23, 2020, the Company received $150,000 from the Small Business Administration (the “SBA”) as an Economic Injury Disaster Loan (“EIDL”,) established under the CARES Act of 2020. The proceeds of this loan require no payments for the first year and then is amortized in equal monthly payments over the next thirty years. The interest rate for an EIDL is 3.75% annually. The collateral for the EIDL is all tangible and intangible personal property.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies and Organization (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	(A) Basis of Presentation The accompanying condensed consolidated unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations. It is management’s opinion that all material adjustments (consisting of normal recurring adjustments) have been made, which are necessary for a fair financial statements’ presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. The Company is a Nevada corporation formed on November 3, 2015. It was formed as a holding company whose principal activities consists of acquiring healthcare technology companies. Its fiscal year end is December 31. To date, the Company has financed and acquired four electronic medical records companies.
Use of Estimates	(B) Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include the allocation of purchase price to fair value of assets acquired, valuation of deferred taxes, allowance for bad debt, useful lives of intangible assets, and stock-based compensation.
Cash and Cash Equivalents	(C) Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At March 31, 2020 and December 31, 2019, the Company had no cash equivalents.
Accounts Receivable	(D) Accounts Receivable Accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. Specific reserves are estimated by management based on certain assumptions and variables, including the customer’s financial condition, age of the customer’s receivables, and changes in payment histories. Accounts receivable are written off when management determines the likelihood of collection is remote. Interest is not charged on accounts receivable that are past due. The Company recorded an allowance for doubtful accounts of $942 and $0 as of March 31, 2020 and December 31, 2019, respectively.
Principles of Consolidation	(E) Principles of Consolidation The 2020 and 2019 consolidated financial statements include the operations of EMR Technology Solutions, Inc. (“EMR”), its wholly owned subsidiaries First Medical Solutions, Inc. (“FMS”), EMRgence, LLC (“EMRG”), Empower Technologies, Inc. (“ETI”), and Digital Medical Solutions, Inc. (“DMSI”). All significant intercompany accounts and transactions have been eliminated in consolidation.
Income Taxes	(F) Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The tax returns for the years ended December 31, 2019, 2018, 2017, and 2016 are subject to examination by the Internal Revenue Service.
Furniture and Computer Equipment	(G) Furniture and Computer Equipment Office Furniture and Computer Equipment are capitalized at cost, net of accumulated depreciation. Depreciation is calculated by using the straight-line method over the estimated useful lives of the assets, which is five to seven years for all categories. Repairs and maintenance are charged to expense as incurred. Expenditures for betterments and renewals are capitalized. The cost of computer equipment and the related accumulated depreciation are removed from the accounts upon retirement or disposal with any resulting gain or loss being recorded in operations. Asset Category Period Furniture and fixtures 7 Years Computer equipment 3 Years
Amortization and Impairment of Long-Lived Assets	(H) Amortization and Impairment of Long-Lived Assets Amortization and Impairment of long-lived assets are non-cash expenses relating primarily to intangible assets. The Company accounts for long-lived assets in accordance with the provisions of FASB ASC 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets”. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Software costs are amortized over three (3) years. Non-compete costs are amortized over three (3) years and Customer Lists are amortized over three (3) years. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. As of March 31, 2020, and December 31, 2019, we have recorded impairments of $0 and $0, respectively. For the three months ended March 31, 2020 and the three months ended March 31, 2019, amortization expense was $55,920 and $145,950, respectively.
Fair Value Measurements and Fair Value of Financial Instruments	(I) Fair Value Measurements and Fair Value of Financial Instruments The Company adopted FASB ASC Topic 820, Fair Value Measurements. ASC Topic 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The Company did not identify any assets or liabilities that are required to be presented on the balance sheets at fair value in accordance with ASC Topic 820 (F).
Advertising	(J) Advertising Advertising costs are expensed as incurred. For the three months ended March 31, 2020 and March 31, 2019, the Company incurred $0 and $0, respectively.
Business Segments	(K) Business Segments The Company operates in one segment and therefore segment information is not presented.
Revenue Recognition	(L) Revenue Recognition The Company accounts for revenue in accordance with Topic 606, which the Company adopted on January 1, 2018, using the modified retrospective method. The adoption of Topic 606 did not have a material impact on the timing or amounts of revenue recognized in our unaudited condensed consolidated financial statements and therefore did not have a material impact on our financial position, results of operations, equity or cash flows as of the adoption date or for the three months ended March 31, 2020. The Company did not recognize any cumulative-effect adjustment to retained earnings upon adoption as the impact was immaterial. Also, the comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. Revenues are recognized when the Company satisfies a performance obligation by transferring control of the promised goods or services to our customers at a point in time, in an amount specified in the contract with our customer and that reflects the consideration The Company expect to be entitled to in exchange for those goods or services. The Company also assesses our customer’s ability and intention to pay, which is based on a variety of factors including our customer’s historical payment experience and financial condition. The Company derives revenue from the sale of software licenses when the products are installed and all required post implementation services are completed. The Company recognizes revenue from consulting services as the services are performed. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer under Topic 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The majority of our contracts with customers contain a single performance obligation to provide agreed-upon products or services. For contracts with multiple performance obligations, we allocate revenue to each performance obligation based on its relative standalone selling price. In accordance with Topic 606, we do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer. The timing of our performance often differs from the timing of invoicing, which results in the recording of deferred revenue. Deferred revenue will be recognized when performance obligation is satisfied.
Stock-Based Compensation	(M) Stock-Based Compensation The Company accounts for stock-based instruments issued to employees for services in accordance with ASC Topic 718. ASC Topic 718 requires the Company to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an employee award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. This standard was effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity’s adoption of Topic 606. The adoption of this ASU has no material impact on our results of operations, cash flows or financial condition.
Cost of Revenue	(N) Cost of Revenue Cost of revenue consists primarily of sub-contractor costs related to personnel who provide services to our customers, co-location costs, and other direct costs related to our services. Costs associated with the implementation of new customers are expensed as incurred.
Basic and Diluted Net Loss Per Common Share	(O) Basic and Diluted Net Loss Per Common Share In accordance with ASC 260-10, “Earnings Per Share”, basic net loss per common share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted loss per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. As of March 31, 2020 and March 31, 2019, the Company has 1,157,133 and 955,038 shares of common stock issuable upon the conversion of notes payable and 90,000 and 90,000 shares of common stock issuable upon the exercise of options, respectively, that were not included in the computation of dilutive loss per share because their inclusion is anti-dilutive.
Recent Accounting Pronouncements	(P) Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02 “Leases,” which will amend current lease accounting to require lessees to recognize (i) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis, and (ii) a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ASU 2016-02 does not significantly change lease accounting requirements applicable to lessors; however, certain changes were made to align, where necessary, lessor accounting with the lessee accounting model. This standard was effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The adoption of this ASU has no material impact on our results of operations, cash flows, or financial condition because the Company’s leases are less than 12 months. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies and Organization (Tables)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Schedule of estimated useful lives of assets	Asset Category Period Furniture and fixtures 7 Years Computer equipment 3 Years

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Schedule of options granted and outstanding	Number of Weighted Granted Intrinsic Options outstanding at December 31, 2019 90,000 $ 0.001 90,000 $ 0 Granted -- -- -- -- Exercised -- -- -- -- Forfeited/Expired -- -- -- -- Options outstanding at March 31, 2020 90,000 $ 0.001 90,000 $ 0

Summary of Significant Accoun_4

Summary of Significant Accounting Policies and Organization (Details)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Furniture and fixtures [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives years of assets	3 years	7 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies and Organization (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Summary of Significant Accounting Policies and Organization (Textual)
Anti-dilutive securities, shares issuance of conversion of notes payable	1,157,133	955,038
Shares of common stock issuable upon the exercise of options	90,000	90,000
Allowance for doubtful accounts	$ 942		$ 0
Advertising expenses	$ 0	$ 0
Description of estimated useful lives of the assets	Depreciation is calculated by using the straight-line method over the estimated useful lives of the assets, which is five to seven years for all categories.
Impairment expense	$ 0		$ 0
Depreciation expense	$ 55,920	$ 145,950
Software [Member]
Summary of Significant Accounting Policies and Organization (Textual)
Amortization period of intangible assets	3 years
Customer Lists [Member]
Summary of Significant Accounting Policies and Organization (Textual)
Amortization period of intangible assets	3 years
Non-compete [Member]
Summary of Significant Accounting Policies and Organization (Textual)
Amortization period of intangible assets	3 years

Promissory Notes and Factor A_2

Promissory Notes and Factor Advances (Details) - USD ($)

Mar. 15, 2019

Oct. 31, 2016

Oct. 31, 2019

Mar. 31, 2019

Sep. 30, 2018

Jun. 30, 2018

Mar. 31, 2018

Dec. 29, 2017

Dec. 20, 2017

Mar. 31, 2020

Mar. 31, 2019

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2017

Apr. 30, 2019

Dec. 22, 2017

Nov. 15, 2017

Promissory Notes and Factor Advances (Textual)

Debt discount

$ 17,138

Balance due

72,838

Amortization of debt discount

$ 7,371

$ 17,089

ETI [Member]

Promissory Notes and Factor Advances (Textual)

Debt collateral, description

The ETI Note was amended to change the beginning repayment period from March 31, 2019 to September 30, 2019 for $37,500 and 3 equal quarterly installments of $37,500 each thereafter.

The ETI Note was amended to change the beginning repayment period from March 31, 2019 to September 30, 2019 for $37,500 and 3 equal quarterly installments of $37,500 each thereafter. On March 31, 2019, the Board of Directors approved an amendment to the ETI Note changing the conversion provision from $3.00 per share to $1.00 per share. On June 30, 2019, the ETI Note was amended to change the beginning repayment period to September 30, 2019 for $75,000 and 2 quarterly installments of $37,500 thereafter

ETI [Member] | Unsecured convertible promissory note [Member]

Promissory Notes and Factor Advances (Textual)

Note term, issued

3 years

Unsecured note

$ 150,000

Interest rate

6.00%

Interest rate, description

An interest rate of six percent (6%) per annum for a period of two (2) years and fully amortizes during the third (3rd) year.

Debt collateral, description

The note can be converted at any time, at the option of the holder, into shares of the Company's stock.

The Board of Directors approved an amendment to the ETI Note changing the conversion provision from $3.00 per share to $1.00 per share. On June 30, 2019, the ETI Note was amended to change the beginning repayment period to September 30, 2019 for $75,000 and 2 quarterly installments of $37,500 thereafter The payments due on September 30, 2019, December 31, 2019, and March 31, 2020 were not paid and the noteholder has not notified the Company of any event of default.

Conversion price

$ 3

FMS [Member]

Promissory Notes and Factor Advances (Textual)

Unsecured note

$ 700,000

$ 700,000

Interest rate

10.00%

10.00%

Interest rate, description

An interest rate of ten percent (10%) per annum for a period of two (2) years and fully amortizes during the third (3rd) year.

Debt collateral, description

The FMS Note was amended to change the beginning repayment period from June 30, 2019 to September 30, 2019 for 3 quarterly installments thereafter.

Conversion price

$ 1

$ 1

FMS [Member] | Minimum [Member]

Promissory Notes and Factor Advances (Textual)

Conversion price

$ 1

FMS [Member] | Maximum [Member]

Promissory Notes and Factor Advances (Textual)

Conversion price

$ 3

FMS [Member] | Convertible Common Stock [Member]

Promissory Notes and Factor Advances (Textual)

Interest rate

6.00%

6.00%

6.00%

6.00%

Interest rate, description

FMS Note accruing at six percent (6.0%) annual interest.

FMS Note accruing at six percent (6.0%) annual interest.

Converted shares of common stock

$ 200,000

$ 33,038

$ 33,038

$ 25,000

Converted shares of common stock, shares

200,000

25,000

Debt discount

$ 29,450

FMS [Member] | Unsecured convertible promissory note [Member]

Promissory Notes and Factor Advances (Textual)

Loss on conversion of debt

$ 72,000

EMRG [Member]

Promissory Notes and Factor Advances (Textual)

Note term, issued

3 years

Unsecured note

$ 200,000

Interest rate

8.00%

Interest rate, description

EMRG Note was amended to change the beginning repayment period from December 31, 2017 to March 31, 2018 for $50,000 and 7 equal quarterly installments of $25,000 each thereafter and the interest rate was increased from 6% to 8% annually.

An interest rate of eight percent (8%) per annum for a period of one (1) years and fully amortizes during the next two (2) years. The note is secured with a pledge of forty percent (40%) of the membership interests acquired.

Debt collateral, description

The EMRG Note was amended to change the beginning repayment period from January 1, 2019 to June 30, 2019 for $125,000 and 2 equal quarterly installments of $37,500 each thereafter. On June 30, 2019, the EMRG Note was amended to change the principal payment of $200,000 and accrued interest to October 31, 2019.

The EMRG Note was amended to change the beginning repayment period from March 31, 2018 to October 1, 2018 for $100,000 and 4 equal quarterly installments of $25,000 each thereafter. On September 30, 2018, the EMRG Note was amended to change the beginning repayment period from March 31, 2018 to January 1, 2019 for $125,000 and 3 equal quarterly installments of $25,000 each thereafter. Effective January 1, 2019, the EMRG Note was amended to change the beginning repayment period from January 1, 2019 to June 30, 2019 for $125,000 and 2 equal quarterly installments of $37,500 each thereafter.

Conversion price

$ 3

DMSI [Member]

Promissory Notes and Factor Advances (Textual)

Debt collateral, description

The Note was amended to change the interest only period from one year to two years, changing the beginning of principal payments from December 31, 2017 to December 31, 2018 and to increase the annual interest rate from 6% to 8% commencing January 1, 2018.

The DMSI Note was amended to change the beginning repayment period from December 31, 2018 to June 30, 2019 for $50,000 and 3 quarterly installments of $50,000 thereafter.

Accounts payable

$ 95,550

DMSI [Member] | Minimum [Member]

Promissory Notes and Factor Advances (Textual)

Conversion price

$ 1

DMSI [Member] | Maximum [Member]

Promissory Notes and Factor Advances (Textual)

Conversion price

$ 3

DMSI [Member] | Unsecured convertible promissory note [Member]

Promissory Notes and Factor Advances (Textual)

Note term, issued

3 years

Unsecured note

$ 250,000

Interest rate

6.00%

Interest rate, description

An interest rate of six percent (6%) per annum for a period of one (1) year and fully amortizes during the next two (2) years.

Debt collateral, description

The note can be converted at any time, at the option of the holder, into shares of the Company's stock.

Conversion price

$ 1

Converted shares of common stock

$ 50,000

Converted shares of common stock, shares

50,000

Third Party [Member] | Revenue Based Factoring Agreement [Member]

Promissory Notes and Factor Advances (Textual)

Interest rate, description

Third party to ACH debit $506 daily from the Company’s bank account until the purchased amount is fully received

Third party to ACH debit $506 daily from the Company’s bank account until the purchased amount is fully received

Debt discount

$ 29,450

$ 29,450

$ 29,450

Balance due

79,701

Net of debt discount

24,509

Amount sold under agreement

124,450

124,450

Amount of accounts and contract rights

$ 95,000

$ 95,000

Amortization of debt discount

$ 5,122

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Jan. 15, 2020	Jan. 15, 2017	Mar. 31, 2020	Mar. 31, 2019
Commitments and Contingencies (Textual)
Monthly rent per month	$ 1,228	$ 1,143
Lease expires date				Jan. 31, 2019
Office lease term	1 year	2 years
Rent expense			$ 3,718	$ 3,628

Stockholders' Equity (Details)

Stockholders' Equity (Details)	3 Months Ended
	Mar. 31, 2020USD ($)$ / sharesshares
Equity [Abstract]
Number of Options, Outstanding beginning balance	90,000
Number of Options, Granted
Number of Options, Exercised
Number of Options, Forfeited/Expired
Number of Options, Outstanding ending balance	90,000
Weighted Average Exercise price, Outstanding beginning balance | $ / shares	$ 0.001
Weighted Average Exercise price, Granted | $ / shares
Weighted Average Exercise price, Exercised | $ / shares
Weighted Average Exercise price, Forfeited/Expired | $ / shares
Weighted Average Exercise price, Outstanding ending balance | $ / shares	$ 0.001
Granted Options Exercisable, Outstanding beginning balance	90,000
Granted Options Exercisable, Granted
Granted Options Exercisable, Exercised
Granted Options Exercisable, Forfeited/Expired
Granted Options Exercisable, Outstanding ending balance	90,000
Intrinsic value, Outstanding beginning balance | $	$ 0
Intrinsic value, Granted
Intrinsic value, Exercised
Intrinsic value, Forfeited/Expired
Intrinsic value, Outstanding ending balance | $	$ 0

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - shares	1 Months Ended	3 Months Ended
	Feb. 15, 2019	Mar. 31, 2020
2016 Plan [Member]
Stockholders' Equity (Textual)
Stock option term		10 years
Stock option vesting period		5 years
Two shareholders [Member]
Stockholders' Equity (Textual)
Common stock shares issued	400
Cancelled shares refunded to shareholders	410